Zeiss Medical Technology has partnered with Boehringer Ingelheim to create predictive analytics to aid with early detection of eye diseases.
The companies will use data analytics and algorithms to detect and treat retinal diseases as early as possible.
“With our announcement today with Boehringer Ingelheim, we’re building on our strategy to innovate through partnerships in order to make breakthrough discoveries to combat vision loss and improve people’s lives,” Euan S. Thomson, PhD, head of the ophthalmology strategic business unit and head of the digital business unit